Comprehensive research of proton therapy solutions
In the quest for the ideal proton therapy solution, Dr. Dosoretz highlights the need to "turn over every rock." This thorough research is essential to guarantee that the chosen partner can deliver a machine that meets all operational requirements and can sustain performance over the years. It's not just about purchasing equipment; it's about ensuring that the system will deliver today and for many years in the future, and the relationship with the partner and the community they bring along will further enhance the cancer treatment services provided by the center.
Discover how ProteusONE provides unmatched value for cancer centers today and for the future here.
Why IBA stands out
For Dr. Dosoretz and his team, IBA emerged as the standout choice. The proton therapy systems manufactured by IBA are deemed superior to those of other vendors, showcasing unmatched precision and reliability. Additionally, the community aspect that IBA provides, opening access to existing centers that have successfully installed proton therapy systems, offers invaluable insights and support, making IBA a compelling partner.
Another key consideration for Dr. Dosoretz was the ability of IBA to provide ongoing technological innovations. The assurance that IBA would keep evolving its products to meet future demands was a significant factor in their decision-making process. This adaptability is crucial in a field that continuously advances, ensuring that their center remains at the cutting edge of proton therapy technology.
The strong cultural alignment with IBA's team also played a vital role in the partnership decision. Dr. Dosoretz noted that the ability to work collaboratively through challenges and find effective solutions was essential for their proton therapy partnership decision.
Click here to find out more about IBA’s commitment to ensuring their partner’s successful proton therapy project implementation and cancer patient care.
ProteusONE, a strategic choice in proton therapy
The ProteusONE system is positioned as a cornerstone of modern proton therapy. Dr. Dosoretz describes it as offering the best of what proton technology has to offer today. With its precision, accuracy, and proven track record, ProteusONE was the best proton therapy machine available in the proton space. The reliability of the equipment, coupled with the strong service support from IBA, assures them that they are making a sound investment.
Dr. Dosoretz also highlights the future innovations IBA is currently working on, including advancements like DynamicARC® and the potential for ConformalFLASH®. These innovations will not only enhance the capabilities of their current system but also ensure that they can adapt to future cancer treatment methodologies, keeping their center at the forefront of proton therapy. As Dr. Dosoretz points out, proton therapy machines have a long lifespan, and the upgradability of ProteusONE and its adaptability to future technological innovations were key in their purchasing decision.
Discover IBA’s commitment to creating the future of proton therapy innovations with DynamicARC®* and ConformalFLASH®*
Conclusion: The right partnership for proton therapy success
In conclusion, selecting the right partner in proton therapy is a multifaceted decision that encompasses technology, community support, cultural fit, and future adaptability. Dr. Dosoretz's insights underline the importance of thorough research and the value of a long-term partnership with a company that prioritizes innovation and reliability. By choosing IBA, they are not just acquiring a machine; they are investing in a future filled with possibilities in proton therapy for decades to come.
Notes
Disclaimer: The statements of the healthcare professional included in this testimonial reflect only his opinion and personal experience. They do not necessarily reflect the opinion of any institution with whom he is affiliated or IBA.
* ConformalFLASH® & DynamicARC® are registered brands of IBA’s Proton Therapy which are currently under research and development. ConformalFLASH® and DynamicARC® will be available for sale when regulatory clearance is received. Due to a continuous research and development program, IBA reserves the right to make changes in design, technical descriptions, and specifications of its products without prior notice. Some features are under development and may be subject to review by competent authorities.
